Center on Health Equity & Access
Clinical
Health Care Cost
Health Care Delivery
Insurance
Policy
Technology
Value-Based Care

Biosimilars Cardiorenalmetabolic Dermatology Gastroenterology Hematology Hepatology Immunology Infectious Disease Mental Health Neurology Obesity Oncology Ophthalmology Pulmonology Rare Disease Respiratory Rheumatology Women's Health

Free In-Person Regional Events Focused on Oncology and Population Health

Biosimilars Center on Health Equity & Access Digital Health Formulary Gene Therapy Guidelines Health Care Administration Health Care Cost Health Care Delivery Insurance Policy Population Health Product Approvals and Launches Technology Value-Based Care

All Coverage Event Coverage Interviews News

AJMC Journals Anniversary Author Forms Authors Nominate a Rising Leader Submit a Manuscript

Providers

Latest News

Hand holding nose spray | Image credit: I Viewfinder – stock.adobe.com

FDA Approves Intranasal Etripamil for Type of Arrhythmia

By Hayden E. Klein

December 16th 2025

Intranasal etripamil was approved to self-treat episodes of paroxysmal supraventricular tachycardia, supported by phase 3 RAPID trial data.

AJMC commentary

Physician-Pharmacy Integration in Cancer Care: Pillars of Medically Integrated Pharmacy

By Gury K. Doshi, MD
Lucio Gordan, MD

December 16th 2025

Brookings photo

Optimizing Oncology Outcomes Through Aligned Payer-Provider Strategies

By Skylar Jeremias

December 15th 2025

Texas Oncology at state capitol | Image: Texas Oncology

Reimbursement Cuts Threaten Access to Cancer Care

By Sabrina McCrear

December 15th 2025

FDA Approved | Image credit: chrisdorney – stock.adobe.com

FDA Approves Once-Monthly PCSK9 Injection for LDL-C Reduction

By Hayden E. Klein

December 15th 2025

...

121 122 123 124 125

Editorial Boards

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences
AJMC®
All rights reserved.